• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS21
Device Problems Perivalvular Leak (1457); Malposition of Device (2616)
Patient Problem Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 11/24/2021
Event Type  Injury  
Event Description
On (b)(6) 2021, a perceval valve pvs21 was attempted to be implanted.The preoperative ct scan showed an aortic valve diameter of 20 mm and st junction diameter of 23 mm.The s-sizer white obturator did not pass through stj and valsalva.When the size was confirmed again with reference to the transparent obturator of s-sizer, it was confirmed that the annulus was large enough for the white obturator to pass through.Perceval size s was selected and the product was implanted.No abnormality was observed visually at the time of implant.After implanting, echocardiography showed pvl between the left coronary cusp and the commissure strut.Pvl was closer to mild than trace.Echo showed that it was difficult to see due to noise and artifacts, but the indwelling position seemed to be a little high, so the device was removed.After removal, sizing was performed after checking around the annulus, another perceval size s was placed.Echo after reimplantation showed that there was no problem with the indwelling position and no regurgitation, and the surgery was completed.The doctor commented that the malposition of the device may be related to severe calcification at the left ventricular outflow tract, and there was no malfunction of the 1st pvs device.The x-clamp time was extended by 44 minutes due to this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc V5J 5 M1
CA  V5J 5M1
MDR Report Key13077724
MDR Text Key284867928
Report Number3019892983-2021-01056
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000412
UDI-Public(01)00896208000412(240)ICV1208(17)231206
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 11/24/2021,12/23/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Expiration Date12/06/2023
Device Model NumberPVS21
Device Catalogue NumberICV1208
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date11/24/2021
Device Age11 MO
Event Location Hospital
Date Report to Manufacturer11/24/2021
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/23/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age82 YR
Patient SexFemale
Patient Weight55 KG
-
-